Coastline Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26K Hold
10
﹤0.01% 397
2026
Q1
$1.39K Hold
10
﹤0.01% 398
2025
Q4
$1.23K Hold
10
﹤0.01% 391
2025
Q3
$1.11K Hold
10
﹤0.01% 388
2025
Q2
$1.11K Hold
10
﹤0.01% 388
2025
Q1
$1.12K Sell
10
-400
-98% -$41.3K ﹤0.01% 386
2024
Q4
$37.9K Sell
410
-1,050
-72% -$94.5K ﹤0.01% 294
2024
Q3
$122K Buy
+1,460
New +$111K 0.01% 237
2024
Q1
Sell
-3,880
Closed -$314K 251
2023
Q4
$314K Sell
3,880
-450
-10% -$35K 0.04% 226
2023
Q3
$324K Sell
4,330
-510
-11% -$39.2K 0.05% 215
2023
Q2
$373K Buy
+4,840
New +$386K 0.05% 220
2023
Q1
Sell
-2,420
Closed -$208K 287
2022
Q4
$208K Buy
+2,420
New +$192K 0.03% 273
2020
Q4
Sell
-4,670
Closed -$295K 319
2020
Q3
$295K Buy
4,670
+210
+5% +$14.6K 0.04% 274
2020
Q2
$343K Buy
4,460
+460
+12% +$35.3K 0.05% 259
2020
Q1
$299K Buy
+4,000
New +$276K 0.05% 260
2019
Q3
Sell
-3,225
Closed -$218K 328
2019
Q2
$218K Hold
3,225
0.03% 310
2019
Q1
$210K Buy
+3,225
New +$214K 0.03% 308
2018
Q4
Sell
-23,655
Closed -$1.83M 313
2018
Q3
$1.83M Buy
23,655
+6,490
+38% +$490K 0.26% 132
2018
Q2
$1.22M Buy
17,165
+3,090
+22% +$218K 0.18% 182
2018
Q1
$1.06M Buy
14,075
+2,950
+27% +$235K 0.16% 186
2017
Q4
$797K Buy
11,125
+2,140
+24% +$163K 0.12% 208
2017
Q3
$728K Buy
8,985
+2,860
+47% +$219K 0.13% 196
2017
Q2
$434K Buy
6,125
+1,120
+22% +$74.5K 0.08% 227
2017
Q1
$340K Buy
+5,005
New +$352K 0.06% 238

Other funds holding GILD

Coastline Trust's GILD Position: Q2 2026 in Review

Coastline Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 10 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Coastline Trust first reported a position in GILD in Q1 2017 and has held it in 24 quarters since. The position peaked at $1.83M in Q3 2018. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Coastline Trust held 10 shares of Gilead Sciences worth $1.26K as of Q2 2026.
  • Coastline Trust left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Coastline Trust's portfolio in Q2 2026, its #397 holding.
  • Coastline Trust first reported a position in Gilead Sciences in Q1 2017 and has held it in 24 quarters since.
  • Coastline Trust's Gilead Sciences position peaked at $1.83M in Q3 2018.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Coastline Trust's 13F filing for Q2 2026, filed 14 Aug 2026.